Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples